Cargando…
Antinuclear antibodies (ANA) patterns in paraneoplastic cerebellar degeneration during the course of disease and treatment protocols – A case report
Paraneoplastic cerebellar degeneration (PCD) is a rare disease that is triggered by an abnormal immune response to a malignant tumor by cross-reaction of antibodies. The low prevalence of this condition has not allowed for large-scale randomized controlled trials. Suspecting a paraneoplastic syndrom...
Autores principales: | Ćerimagić, A., Džananović, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388409/ https://www.ncbi.nlm.nih.gov/pubmed/32743519 http://dx.doi.org/10.1016/j.jtauto.2020.100034 |
Ejemplares similares
-
Can Antinuclear Antibodies (ANA) be Monoclonal?
por: Biederman, Laura, et al.
Publicado: (2021) -
The Past, Present, and Future in Antinuclear Antibodies (ANA)
por: Irure-Ventura, Juan, et al.
Publicado: (2022) -
Treatment of Paraneoplastic Cerebellar Degeneration
por: Greenlee, John E.
Publicado: (2013) -
A Rare Case of Antinuclear Antibody (ANA)-Negative Lupus Nephritis
por: Bakshi, Nayaab, et al.
Publicado: (2023) -
Update on Paraneoplastic Cerebellar Degeneration
por: Loehrer, Philipp Alexander, et al.
Publicado: (2021)